Sprint Fidelis Lead Claims Preempted by Federal Law, Court Affirms

LOS ANGELES - State law claims brought against Medtronic Inc. in connection with its recalled Sprint Fidelis Lead are preempted by the Medical Device Amendments to the Food Drug and Cosmetic Act because they would impose state requirements that are "different from or in addition to" federal requirements, a California appellate court has affirmed. Bagumyan v. Medtronic Inc., No. B219506 (Calif. App., 2nd Dist.).

On Oct. 16, the California Court of Appeal, 2nd District, upheld a ruling by the Los Angeles County Superior Court.

Medtronic designed, manufactured and sold the Sprint Fidelis Lead, a wire that delivers signals that allow …